ORCID
0000-0002-9906-7058
Keywords
Immunometabolism, GPR84, nutrient sensing receptor, mitochondrial fitness, PD-1 resistance, cancer immunotherapy.
Subject Categories
Cancer Biology | Cell Biology
Abstract
The tumor microenvironment (TME) remains a major barrier to effective cancer immunotherapy. Upon entering tumors, T cells encounter a hostile environment characterized by nutrient deprivation, hypoxia, acidosis, and immunosuppressive signals that collectively impair their survival, metabolic fitness, and effector function. The ability of T cells to adapt to these conditions is therefore a critical determinant of successful anti-tumor immunity. However, the pathways that link environmental signals to T-cell metabolic adaptation remain incompletely understood. This work investigates the role of the medium-chain fatty acid (MCFA)-sensing receptor GPR84 in regulating T-cell responses during cancer. Our findings show that loss of GPR84 enhances tumor control and promotes the accumulation of functionally superior CD4⁺ and CD8⁺ T cells within tumors. In the absence of GPR84, T cells exhibit increased proliferation, persistence, and polyfunctional cytokine production, together with reduced expression of inhibitory receptors associated with T-cell dysfunction. Mechanistically, GPR84 deficiency improves metabolic fitness by enhancing mitochondrial activity and cellular bioenergetics, enabling T cells to better adapt to the metabolic challenges of the TME. In adoptive cell therapy models, GPR84-deficient T cells display superior expansion and antitumor activity, resulting in improved control of tumor growth. Importantly, pharmacological inhibition of GPR84 recapitulates many of these effects and enhances the efficacy of existing immunotherapeutic approaches. Collectively, these findings establish GPR84 as a critical regulator of T-cell metabolic adaptation and antitumor function and reveal extracellular lipid sensing as a targetable pathway in cancer immunity. Proposing GPR84 inhibition as a promising strategy to improve the effectiveness of T cell-based immunotherapies.
Completion Date
2026
Semester
Summer
Committee Chair
Nguyen, Hung
Degree
Doctor of Philosophy (Ph.D.)
College
College of Medicine
Department
Burnett School of Biomedical Sciences
Format
Document Type
Dissertation
Language
English
Release Date
8-15-2028
STARS Citation
Morales Alvarez, Anamaria, "GPR84: A Novel Immuno-Metabolic Checkpoint in Cancer Immunotherapy" (2026). Graduate Studies Theses and Dissertations 2026. 317.
https://stars.library.ucf.edu/gradstudies_etd_2026/317
Accessibility Statement
This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.